Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra Duffy

Showing results (81-90 of 94) with videos related to

Pageof 10
Sort By:
Nature Microbiology|August 16, 2017
Hexahydroquinolines are antimalarial candidates with potent blood-stage and transmission-blocking activityManu Vanaerschot, Leonardo Lucantoni, Tao Li, et al.
Chemmedchem|June 13, 2019
Substituted Aminoacetamides as Novel Leads for Malaria TreatmentNeil R Norcross, Caroline Wilson, Beatriz Baragaña, et al.
ACS Infectious Diseases|April 30, 2021
Repositioning and Characterization of 1-(Pyridin-4-yl)pyrrolidin-2-one Derivatives as <i>Plasmodium</i> Cytoplasmic Prolyl-tRNA Synthetase InhibitorsMasanori Okaniwa, Akira Shibata, Atsuko Ochida, et al.
Journal of Medicinal Chemistry|February 5, 2019
3,3'-Disubstituted 5,5'-Bi(1,2,4-triazine) Derivatives with Potent in Vitro and in Vivo Antimalarial ActivityLian Xue, Da-Hua Shi, Jitendra R Harjani, et al.
Journal of Medicinal Chemistry|June 18, 2016
Trisubstituted Pyrimidines as Efficacious and Fast-Acting AntimalarialsNeil R Norcross, Beatriz Baragaña, Caroline Wilson, et al.
Journal of Medicinal Chemistry|July 10, 2014
N-aryl-2-aminobenzimidazoles: novel, efficacious, antimalarial lead compoundsSreekanth Ramachandran, Shahul Hameed P, Abhishek Srivastava, et al.
Nature|May 21, 2010
Chemical genetics of Plasmodium falciparumW Armand Guiguemde, Anang A Shelat, David Bouck, et al.
Journal of Medicinal Chemistry|June 11, 2014
Aminoazabenzimidazoles, a novel class of orally active antimalarial agentsShahul Hameed P, Murugan Chinnapattu, Gajanan Shanbag, et al.
Science Translational Medicine|March 22, 2013
Quinolone-3-diarylethers: a new class of antimalarial drugAaron Nilsen, Alexis N LaCrue, Karen L White, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 3, 2014
(+)-SJ733, a clinical candidate for malaria that acts through ATP4 to induce rapid host-mediated clearance of PlasmodiumMaría Belén Jiménez-Díaz, Daniel Ebert, Yandira Salinas, et al.
Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
Nature Microbiology|August 16, 2017
Hexahydroquinolines are antimalarial candidates with potent blood-stage and transmission-blocking activityManu Vanaerschot, Leonardo Lucantoni, Tao Li, et al.
Chemmedchem|June 13, 2019
Substituted Aminoacetamides as Novel Leads for Malaria TreatmentNeil R Norcross, Caroline Wilson, Beatriz Baragaña, et al.
ACS Infectious Diseases|April 30, 2021
Repositioning and Characterization of 1-(Pyridin-4-yl)pyrrolidin-2-one Derivatives as <i>Plasmodium</i> Cytoplasmic Prolyl-tRNA Synthetase InhibitorsMasanori Okaniwa, Akira Shibata, Atsuko Ochida, et al.
Journal of Medicinal Chemistry|February 5, 2019
3,3'-Disubstituted 5,5'-Bi(1,2,4-triazine) Derivatives with Potent in Vitro and in Vivo Antimalarial ActivityLian Xue, Da-Hua Shi, Jitendra R Harjani, et al.
Journal of Medicinal Chemistry|June 18, 2016
Trisubstituted Pyrimidines as Efficacious and Fast-Acting AntimalarialsNeil R Norcross, Beatriz Baragaña, Caroline Wilson, et al.
Journal of Medicinal Chemistry|July 10, 2014
N-aryl-2-aminobenzimidazoles: novel, efficacious, antimalarial lead compoundsSreekanth Ramachandran, Shahul Hameed P, Abhishek Srivastava, et al.
Nature|May 21, 2010
Chemical genetics of Plasmodium falciparumW Armand Guiguemde, Anang A Shelat, David Bouck, et al.
Journal of Medicinal Chemistry|June 11, 2014
Aminoazabenzimidazoles, a novel class of orally active antimalarial agentsShahul Hameed P, Murugan Chinnapattu, Gajanan Shanbag, et al.
Science Translational Medicine|March 22, 2013
Quinolone-3-diarylethers: a new class of antimalarial drugAaron Nilsen, Alexis N LaCrue, Karen L White, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 3, 2014
(+)-SJ733, a clinical candidate for malaria that acts through ATP4 to induce rapid host-mediated clearance of PlasmodiumMaría Belén Jiménez-Díaz, Daniel Ebert, Yandira Salinas, et al.
Pageof 10